Skip to main content

Research Repository

Advanced Search

Dr Mwidimi Ndosi's Outputs (26)

POS1477-HPR Understanding treatment utilisation in individuals with osteoarthritis and metabolic multimorbidity: A cross-sectional study (2024)
Presentation / Conference Contribution

Background: Osteoarthritis (OA) and metabolic conditions are major causes of disability. A growing hypothesis posits the presence of a metabolic OA phenotype where the co-occurrence of OA and metabolic conditions may worsen joint symptoms and overall... Read More about POS1477-HPR Understanding treatment utilisation in individuals with osteoarthritis and metabolic multimorbidity: A cross-sectional study.

AB1575-HPR Geographical differences in osteoarthritis care management: A European cross-sectional study (2024)
Presentation / Conference Contribution

Background: Osteoarthritis (OA) burdens individuals and healthcare systems across Europe. With limited curative options, symptom management becomes pivotal, yet underdiagnosis and varied healthcare professional education in OA prevail. The role of in... Read More about AB1575-HPR Geographical differences in osteoarthritis care management: A European cross-sectional study.

AB1429 Sociodemographic and clinical factors associated with health-related quality of life in patients with inflammatory rheumatic diseases treated with glucocorticoids: A cross-sectional study (2024)
Presentation / Conference Contribution

Background: Glucocorticoids (GCs) play a pivotal role in the management of inflammatory rheumatic conditions but they can adversely impact on patients in different ways. Conversely, there are certain patient charact... Read More about AB1429 Sociodemographic and clinical factors associated with health-related quality of life in patients with inflammatory rheumatic diseases treated with glucocorticoids: A cross-sectional study.

P041 Health-related quality of life in patients receiving glucocorticoids for a rheumatic disease and associated factors: A cross-sectional study (2024)
Presentation / Conference Contribution

Background/Aims Glucocorticoids (GCs) used in the treatment of inflammatory rheumatic conditions can impact on patients in different ways. The objective of this study was to identify socio-demographic and clinical factors associated with health-relat... Read More about P041 Health-related quality of life in patients receiving glucocorticoids for a rheumatic disease and associated factors: A cross-sectional study.

Association between metabolic conditions and satisfaction with care in people with knee or hip osteoarthritis: a survey-based study (2024)
Presentation / Conference Contribution

Purpose (the aim of the study): Satisfaction measures have been recommended as a core component for evaluating treatment outcomes in osteoarthritis (OA). People with comorbid metabolic conditions and OA need to rely on multiple interventions and may... Read More about Association between metabolic conditions and satisfaction with care in people with knee or hip osteoarthritis: a survey-based study.

E038 A common measure of the impact of glucocorticoids in patients with inflammatory and autoimmune conditions - The Steroid PRO: A cross-cultural validation study with Rasch models (2023)
Presentation / Conference Contribution

Background/Aims Systemic glucocorticoids are key in the management of life- and organ-threatening rheumatic diseases, but have wide-ranging adverse effects of concern to patients and clinicians. We aimed to validate a Patient Reported Outcome (PRO) m... Read More about E038 A common measure of the impact of glucocorticoids in patients with inflammatory and autoimmune conditions - The Steroid PRO: A cross-cultural validation study with Rasch models.

POS0003 Development and validation of a disease specific patient reported outcome for giant cell arteritis (2022)
Presentation / Conference Contribution

Background
Giant cell arteritis (GCA) is caused by inflammation of the blood vessels of the head and neck; patients can present with cranial, ocular or large vessel vasculitis involvement. Treatment is with glucocorticoids, steroid sparing agents a... Read More about POS0003 Development and validation of a disease specific patient reported outcome for giant cell arteritis.

Clinicians’ perspectives on psychological distress and meeting patients’ support needs in rheumatology care settings (2021)
Presentation / Conference Contribution

Background: People with inflammatory rheumatic diseases (IRDs) face challenges that include fluctuations in pain, fatigue and flares of disease activity, complex medical regimens, and decisions about when to seek cl... Read More about Clinicians’ perspectives on psychological distress and meeting patients’ support needs in rheumatology care settings.

AB0834 Development of a conceptual framework for a patient reported outcome measure to capture patients’ perceptions of glucocorticoid therapy during treatment for rheumatic diseases (2021)
Presentation / Conference Contribution

Background: Glucocorticoids (GCs) are a key treatment for the autoimmune rheumatic diseases; however, they produce numerous physical and psychological side effects.1 The Outcome Measures in Rheumatology (OMERACT) Gl... Read More about AB0834 Development of a conceptual framework for a patient reported outcome measure to capture patients’ perceptions of glucocorticoid therapy during treatment for rheumatic diseases.

O26 Testing an intervention to reduce fatigue impact in inflammatory arthritis: Design and outcomes of a single-arm feasibility study (2021)
Presentation / Conference Contribution

Background/Aims Patients with inflammatory arthritis report that fatigue can be a challenging symptom to manage, with little support available. In response, we developed a brief one-to-one cognitive-behavioural manualised intervention, delivered by r... Read More about O26 Testing an intervention to reduce fatigue impact in inflammatory arthritis: Design and outcomes of a single-arm feasibility study.

Dissemination and assessing implementation of the EULAR recommendations for patient education for people with inflammatory arthritis across Europe (2020)
Presentation / Conference Contribution

Background: EULAR recommendations for patient education for people with inflammatory arthritis (IA) were published in 2015.1 This is the first systematic dissemination and implementation study, reporting qualitative data identifying barriers to imple... Read More about Dissemination and assessing implementation of the EULAR recommendations for patient education for people with inflammatory arthritis across Europe.

Revisiting the remission criteria for rheumatoid arthritis by excluding patient global assessment: An individual patient meta-analysis including 5792 patients (2020)
Presentation / Conference Contribution

Background: Remission nowadays is the guiding target of management of rheumatoid arthritis (RA). However, no gold standard definition of remission exists and the inclusion of patient global assessment (PGA) in remis... Read More about Revisiting the remission criteria for rheumatoid arthritis by excluding patient global assessment: An individual patient meta-analysis including 5792 patients.

Revision and validation of the German version of the Systemic Sclerosis Quality of Life Questionnaire (SScQoL) with Mokken scale analysis (2020)
Presentation / Conference Contribution

In the validation study, German-speaking SSc patients included in the Swiss MANagement Of Systemic Sclerosis (MANOSS) cross-sectional study completed the revised (polytomous) SScQoL. Mokken model was used to test the construct valid... Read More about Revision and validation of the German version of the Systemic Sclerosis Quality of Life Questionnaire (SScQoL) with Mokken scale analysis.